IT1284139B1 - PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME - Google Patents

PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME

Info

Publication number
IT1284139B1
IT1284139B1 IT96MI001834A ITMI961834A IT1284139B1 IT 1284139 B1 IT1284139 B1 IT 1284139B1 IT 96MI001834 A IT96MI001834 A IT 96MI001834A IT MI961834 A ITMI961834 A IT MI961834A IT 1284139 B1 IT1284139 B1 IT 1284139B1
Authority
IT
Italy
Prior art keywords
immunodeficence
coenzyme
syndrome
acquired
useful
Prior art date
Application number
IT96MI001834A
Other languages
Italian (it)
Inventor
Raffaele Ansovini
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Priority to IT96MI001834A priority Critical patent/IT1284139B1/en
Priority to ZA9706895A priority patent/ZA976895B/en
Priority to PCT/EP1997/004886 priority patent/WO1998009634A1/en
Priority to AU44578/97A priority patent/AU4457897A/en
Priority to ARP970104005A priority patent/AR009513A1/en
Publication of ITMI961834A1 publication Critical patent/ITMI961834A1/en
Application granted granted Critical
Publication of IT1284139B1 publication Critical patent/IT1284139B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT96MI001834A 1996-09-06 1996-09-06 PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME IT1284139B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT96MI001834A IT1284139B1 (en) 1996-09-06 1996-09-06 PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME
ZA9706895A ZA976895B (en) 1996-09-06 1997-08-01 Pharmaceutical composition comprising a coenzyme useful in the treatment of acquired immunodeficiency syndrome.
PCT/EP1997/004886 WO1998009634A1 (en) 1996-09-06 1997-08-27 Nad or nadp containing pharmaceutical compositions for treating aids
AU44578/97A AU4457897A (en) 1996-09-06 1997-08-27 Nad or nadp containing pharmaceutical compositions for treating aids
ARP970104005A AR009513A1 (en) 1996-09-06 1997-09-03 PHARMACEUTICAL COMPOSITION THAT INCLUDES A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001834A IT1284139B1 (en) 1996-09-06 1996-09-06 PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME

Publications (2)

Publication Number Publication Date
ITMI961834A1 ITMI961834A1 (en) 1998-03-06
IT1284139B1 true IT1284139B1 (en) 1998-05-08

Family

ID=11374849

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI001834A IT1284139B1 (en) 1996-09-06 1996-09-06 PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME

Country Status (5)

Country Link
AR (1) AR009513A1 (en)
AU (1) AU4457897A (en)
IT (1) IT1284139B1 (en)
WO (1) WO1998009634A1 (en)
ZA (1) ZA976895B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401504B1 (en) * 2010-08-02 2013-07-26 Cattarini Mastelli COMPOSITION INCLUDING GLUTATION AND REDUCTASE AND OXIDIZED GLUTATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222419A (en) * 1983-05-31 1984-12-14 Sankyo Co Ltd Cholesterol-lowering agent
US5051353A (en) * 1988-08-09 1991-09-24 The United States Of America As Represented By The Secretary Of The Navy Preservation and restoration of hemoglobin in blood substitutes
FR2715303A1 (en) * 1991-04-02 1995-07-28 Berque Jean Riboflavin for treating human immunodeficiency virus related diseases
EP0638315B1 (en) * 1993-08-13 1998-11-18 Nikolai Vasilievich Karsanov Antihypoxic agent
FR2718353B3 (en) * 1994-04-11 1996-06-28 Jean Berque Pharmaceutical compositions based on non-toxic biological products intended for the local protection of the genital and rectal mucosa.

Also Published As

Publication number Publication date
AU4457897A (en) 1998-03-26
ITMI961834A1 (en) 1998-03-06
AR009513A1 (en) 2000-04-26
WO1998009634A1 (en) 1998-03-12
ZA976895B (en) 1998-02-18

Similar Documents

Publication Publication Date Title
DE69726015D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING KOENZYM Q-10
NO962606L (en) Pharmaceutical composition
ID16420A (en) NEW PHARMACEUTICAL COMPOSITION WITH ANASTESIA EFFECTS
ATE312602T1 (en) EXTENDED-RELEASE ORAL PHARMACEUTICAL DOSAGE FORM
FI955311A0 (en) Pharmaceutical composition base
DE59712959D1 (en) ORAL PHARMACEUTICAL PREPARATION CONTAINING IBANDRONAT
DE69614407D1 (en) PHARMACEUTICAL COMPOSITIONS
BR9507768A (en) Pharmaceutical composition
ATE208364T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A-OXO-BUTANIC ACIDS
BR9806083A (en) Pharmaceutical composition for the treatment of hapattite c
ID18698A (en) PHARMACEUTICAL COMPOSITION
FI973280A (en) Pharmaceutical composition
IT1284139B1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME
FI951155A0 (en) Pharmaceutical preparation
DE19681529D2 (en) Pharmaceutical dosage form
ITMI942050A0 (en) ROTATING OFFICE CHAIR
BR9605777A (en) Pharmaceutical composition
NO964309D0 (en) Pharmaceutical composition
NO990948D0 (en) Use of PKC Inhibitors in the Preparation of a Medication for the Treatment of HTLV-1 Infections
IT1290436B1 (en) DIETARY SUPPLEMENTS FOR THE TREATMENT OF MENSTRUAL SYNDROME
SE9402432D0 (en) New pharmaceutical dosage form
IT245614Y1 (en) POOL TABLE
SE9402433D0 (en) New oral pharmaceutical dosage form
SE9601854D0 (en) Pharmaceutical composition
ID17133A (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
0001 Granted